Abstract. Cardiomyocytes express both β 1 -and β 2 -adrenergic receptors, and these receptors play a differential role in chronotropic and inotropic effects of the heart. Caveolae are known as an important regulator of G-protein-coupled receptor signaling. In the present report, we examined whether caveolae have a role in β-adrenergic receptor-stimulated cAMP production and protein kinase A activation in neonatal myocytes. Isoproterenol-stimulated cAMP production was mediated by β 1 -and β 2 -subtypes, which depends on the receptor number of each subtype. However, protein kinase A activation was exclusively mediated by the β 1 -subtype. Disruption of caveolae by methyl-β-cyclodextrin treatment did not affect the relative contribution of subtypes to isoproterenol-stimulated cAMP production. β 1 -Subtype-mediated protein kinase A activation was also not affected by the disruption of caveolae. These results suggest that β 1 -adrenergic receptor-mediated protein kinase A activation is compartmentalized and independent of caveolae.
Introduction β-Adrenergic receptor (β-AR) is classified into three subtypes: β 1 , β 2 , and β 3 . Cardiomyocytes express β 1 -and β 2 -sybtypes. The number of β 1 -and β 2 -ARs is 70 -80% and 20 -30% of the total β-ARs, respectively. These subtypes couple with heterotrimeric G-protein G s and activate protein kinase A (PKA) through production of cAMP (1) . PKA activation predominantly mediated by β 1 -AR regulates heart rate and contraction through phosphorylation of key target proteins such as L-type calcium channel, phospholamban, and troponin I (2, 3). However, it has been reported in cardiomyocytes prepared from β 1 -AR knockout mice that the effect of isoproterenol on the contraction rate is evident and biphasic with an initial increase followed by a sustained decrease that is inhibited by pertussis toxin (PTX) treatment (4) . These data indicate that β 1 -AR couples with G s . It also indicates that β 2 -AR couples with G i as well as G s . Although β 1 -and β 2 -ARs increase the contraction rate, there is a difference about the signaling pathway downstream of β 1 -and β 2 -ARs activation. In cardiomyocytes or β 1 -AR transgenic mouse heart, sustained activation of β 1 -AR induces apoptosis, but β 2 -AR stimulation elicits a cardiac protective effect against apoptosis (5 -7) . These results suggest that the responses regulated by β 1 -AR and β 2 -AR are mediated by different signal transduction pathways.
There are microdomains on the cell surface that participate in cellular signal transduction. Lipid rafts are small and mobile membrane subdomains, and caveolae are flask-shaped invaginations on the cell surface containing caveolin. Both lipid rafts and caveolae are highly enriched in cholesterol and lipids with saturated acyl side-chains and resist solubilization by non-ionic detergents such as Triton X-100 at low temperatures. Many proteins participating in signaling are localized in the lipid rafts and caveolae (8) . The mammalian caveolin gene family consists of three members: caveolin-1, caveolin-2, and caveolin-3. Caveolin-3 is dominantly expressed in muscle tissues including the heart (9). In neonatal mouse cardiomyocytes, caveolin-3 associates with β 2 -but not β 1 -ARs, and this association depends on cholesterol content (10) . It was reported that β 1 -AR and Gα s are localized in the caveolae and other cell surface areas, whereas β 2 -AR and Gα i are localized in the caveolae in cardiomyocytes (11) . Another report using adult rat cardiomyocytes showed that caveolin-3 is coimmunoprecipitated with Gα sL but not Gα sS (12) . Thus, two β-AR subtypes show differential localization and signaling in cardiomyocytes. In the present study, we examined the role of caveolae in β 1 -or β 2 -ARsmediated signaling in rat neonatal cardiomyocytes.
Materials and Methods

Materials
Isoproterenol, methyl-β-cyclodextrin (MβCD), CGP-20712A, and ICI-118,551 were purchased from SigmaAldrich (St. Louis, MO, USA). DMEM and penicillin / streptomycin were from Invitrogen (Carlsbad, CA, USA). Collagenase, liberase, and Fugene 6 were from Roche Diagnostics (Mannheim, Germany).
Cell culture and adenovirus infection
Cardiomyocytes were isolated from 1 -2-day-old Sprague-Dawley rats as described previously (13) . Cells were plated on 2% gelatin-coated plates and cultured in DMEM with 5% FBS at the density of 3 × 10 6 cells / mL. After 24 h, the cells were infected with recombinant adenoviruses for 2 h at 37°C. Cells were then starved in serum-free DMEM containing 10 nM insulin and 5 mM taurine and then cultured for an additional 48 h before stimulation.
Immunoflouresence microscopy
Cardiomyocytes were cultured on glass-bottom 35-mm dishes and transfected with HA-tagged β 1 -or β 2 -ARs for 48 h using Fugene 6. The cells were then fixed by 4% paraformaldehyde and permeabilized with phosphate-buffered saline containing 0.2% Nonidet P-40. Cells were stained with mouse anti-caveolin 3 monoclonal antibody (1:600 dilution) from BD Biosciences (Sparks, MD, USA), and FITC-conjugated anti-HA antibody (rabbit monoclonal IgG, 1:200 dilution) from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The primary antibodies were detected with Alexa fluor 546 goat anti-mouse IgG (1:100,000 dilution) from Molecular Probes (Eugene, OR, USA) and Alexa fluor 488 goat anti-rabbit IgG (1:1,000 dilution) from Molecular Probes. The images were obtained with a Laser Scanning Confocal Imaging System (LSM510; Carl Zeiss, Jena, Germany).
Assay of cAMP accumulation
After 24-h starvation, cells were incubated overnight in culture medium containing 1 µCi/ 
Determination of VASP (vasodilator-stimulated phosphoprotein) phosphorylation
Cardiomyocytes in 6 wells dishes were infected with adenovirus expressing Flag-tagged VASP at 50 MOI (multiplicity of infection). Forty-eight hours after infection, cells were stimulated with isoproterenol and harvested with RIPA buffer, and VASP was detected by immunoblotting analysis using anti-Flag antibody (mouse monoclonal IgG 1:10,000 dilution) from SigmaAldrich.
Plasmid construction and production of adenoviruses
The plasmids encoding human β 1 -and β 2 -ARs and a mutant of regulatory subunit of PKA (PKAδR1α) were provided by Drs. Robert J. Lefkowitz and Stanley McKnight, respectively. As PKAδR1α binds the catalytic subunit of PKA, but cannot bind cAMP, it behaves as a dominant negative mutant of the regulatory subunit of PKA. The tag of hemagglutinin (HA) was introduced at the amino-terminus of β 1 -and β 2 -ARs (15). Adenoviruses expressing VASP, GFP, and PKAδR1α were produced as described (16) .
Statistical analyses
The experiments were repeated at least three times, and the results are shown as the mean ± S.E.M. P values are calculated with Student's t-test.
Results
Localization of β 1 -, β 2 -ARs and caveolin-3
At first, we examined the localization of β 1 -, β 2 -ARs and caveolin-3 in cardiomyocytes. Figure 1 shows immunostaining of caveolin-3, which is a marker of caveolae ( Fig. 1 : C and D). Caveolae were stained as punctate. However, this punctate staining was changed to a diffused pattern by the treatment with 10 mM MβCD that extracts cholesterol from the caveolae and disrupts them (data not shown). Figure 1 also shows the localization of HA-tagged β 1 -and β 2 -ARs expressed in cardiomyocytes ( Fig. 1: A and B) . We could not detect significant amount of HA-tagged β 1 -and β 2 -ARs because the transfection efficiency by Fugene 6 was less than 2%. Localization of β 1 -AR does not match that of caveolin-3, indicating that β 1 -AR is largely localized outside of the caveolae (Fig. 1E ). In contrast with β 1 -AR, a portion of β 2 -AR was localized in the caveolae (Fig. 1F) . Therefore, β 1 -AR is almost exclusively localized outside of the caveolae and β 2 -AR is localized in the caveolae and non-caveolae areas.
Effect of MβCD on cAMP production by β 1 -and β 2 -ARs stimulation
We next examined cAMP contents by receptor stimulation. Stimulation of β 1 -and β 2 -ARs increases cAMP through activation of G s and adenylyl cyclase. As a β 1 -selective agonist was not commercially available, cardiomyocytes were stimulated with non-selective β-AR agonist isoproterenol in the presence of a subtypeselective antagonist such as CGP-20712A (β 1 -selective antagonist) or ICI-118,551 (β 2 -selective antagonist). CGP-20712A inhibited cAMP accumulation in a dosedependent manner ( Fig. 2A) . ICI-118,551 also inhibited cAMP production. However, the inhibition curve by ICI-118,551 was biphasic. The two phases of the inhibition curve reflect the differential affinities of ICI-118,551 for β 1 -and β 2 -ARs. Using human hearts and [ 3.0 × 10 −6 M, respectively (17) . Thus, ICI-118,551 has approximately 100 times higher affinity for β 2 -AR and CGP-20712A has approximately 430 times higher affinity for β 1 -AR. This difference explains the apparent two phase of inhibition curve. Inhibition at a low dose of ICI-118,551 represents β 2 -AR-mediated cAMP production. Based on the inhibition curves, β 2 -AR-mediated cAMP production represents about 23% of the total cAMP production by β-AR stimulation. CGP-20712A inhibited cAMP production to about 80% of the total production in a single phase, indicating that about 20% of the cAMP production is mediated by β 2 -AR. Thus, about 20% of the cAMP production is mediated by β 2 -AR. This percentage is roughly equal to the abundance of β 2 -AR.
As β 2 -but not β 1 -ARs were localized in the caveolae and non-caveolae areas, we examined whether the disruption of caveolae would affect receptor-stimulated cAMP production. Cardiomyocytes were treated with MβCD. We then determined cAMP production with isoproterenol stimulation in the presence of 10 −7 M CGP-20712A or 10 −7 M ICI-118,551. These concentrations of CGP-20712A and ICI-118,551 were chosen to selectively inhibit cAMP production mediated by β 1 -and β 2 -ARs stimulation, respectively (see Fig. 2A ). Cyclic AMP production by β 1 -and β 2 -ARs stimulation was increased by pretreatment of MβCD (Fig. 2B) . However, the relative contribution of each subtype to isoproterenol-stimulated cAMP production was not significantly changed (Fig. 2B) .
Effects of MβCD on PKA activation by β 1 -and β 2 -ARs stimulation PKA is the major kinase that is activated by cAMP, and PKA activates many downstream signaling proteins such as mitogen-activated protein kinase. We examined PKA activation by β 1 -and β 2 -ARs stimulation. PKA activation was assessed by the phosphorylation state of VASP. VASP was originally discovered as a substrate for PKA and protein kinase G in human platelets and is a useful tool to detect the activation of these kinases, as the mobility of VASP on SDS-polyacrylamide gel is retarded by phosphorylation (18) . In cardiomyocytes expressing Flag-tagged VASP, isoproterenol stimulation resulted in VASP phosphorylation. This phosphorylation was almost completely inhibited by PKAδR1α (a dominant negative mutant of the regulatory subunit of PKA) (Fig. 3C ). This result indicates that isoproterenol-stimulated VASP phosphorylation is mediated only by PKA activation. To determine the relative contribution of β 1 -and β 2 -ARs to PKA activation, cardiomyocytes were stimulated with isoproterenol in the presence of CGP-20712A or ICI-118,551. CGP-20712A inhibited PKA activation in a dose-dependent manner, similar to the inhibition curve of cAMP production (Fig. 3: A and B) . However, ICI-118,551 did not inhibit PKA activation up to 10 −6 M. These data show that PKA is mainly activated through β 1 -AR. It also indicates that β 2 -AR-stimulated cAMP production does not participate in PKA activation, although β 2 -AR stimulation increases cAMP contents.
We next examined whether disruption of caveolae influences PKA activation. To evaluate β 1 -and β 2 -ARsmediated PKA activation separately, we included CGP-20712A or ICI-118,551 at the concentration of 10 −6 M. β 1 -Adrenergic receptor-stimulated VASP phosphorylation was strongly inhibited by CGP-20712A and partially inhibited by ICI-118,551 under the present conditions (Fig. 3: A and D) . When the cells were treated with MβCD, isoproterenol-stimulated PKA activation was slightly but not significantly decreased (Fig. 3D) . However, PKA activation in the presence of CGP-20712A or ICI-118,551 in MβCD-treated cells was essentially the same as that of the untreated cells. This result suggests that PKA activation by β 1 -AR stimulation is independent of caveolae.
Discussion
The present study demonstrated the localization of β 1 -and β 2 -ARs and the role of caveolae on β-AR-mediated cAMP production and PKA activation in rat neonatal myocytes. β 1 -AR was localized exclusively in the noncaveolae areas, and β 2 -AR was localized in the caveolae and non-caveolae areas. Stimulation of β-ARs with isoproterenol increased cAMP production, and the ratio of β 1 -and β 2 -subtype-mediated cAMP production was almost equal to the proportion of expression level of each subtype. Cyclic AMP production through β 1 -and β 2 -ARs was enhanced by the disruption of caveolae. However, β-AR-stimulated PKA activation was almost exclusively mediated by the β 1 -subtype, and independent of caveolae.
It has been reported that the localization of FLAGtagged β 2 -AR is well-matched to caveolin-3 in mouse neonatal cardiomyocytes (10) . However, the present result showed that only a portion of β 2 -AR is localized in the caveolae (Fig. 1) . One of possibilities to explain this difference is the level of expression. When the amount of β-AR exceeds the cell's capacity to accommodate it, β-AR may not traffic to the proper domain in cells. The myocytes prepared from different species may also explain this difference. We used rat neonatal myocytes in the present study. However, they used mouse neonatal myocytes prepared from β 1 -and β 2 -ARs knockout mice (10) . Mouse neonatal myocytes may have the ability to accommodate larger amounts of β-ARs. Species difference of β-ARs may be another factor for this difference. We expressed human β 1 -and β 2 -ARs, and they expressed mouse β 1 -and β 2 -ARs. As mouse β 1 -AR but not human β 1 -AR internalizes upon agonist stimulation (19, 20) , mouse β-ARs translocate to a specific domain more efficiently than human β-ARs. In the literature, there is controversy about the localization of β-AR subtypes. Ostrom et al. reported that HA-tagged β 1 -AR heterogeneously expressed in cardiomyocytes is detected as a single 72-kDa band in the caveolae fraction (21) . However, Rybin et al. reported that endogenous β 1 -AR in cardiomyocytes is identified as multiple species that distribute over the caveolae and non-caveolae fractions (11) . The precise mechanism to explain these differences is unknown.
Stimulation of β 1 -and β 2 -ARs increases cAMP production through G s and adenylyl cyclase. The present results showed that cAMP production mediated by β 2 -AR accounted for about 20% of the isoproterenol-stimulated cAMP production ( Fig. 2A) , and this percentage is approximately equal to the abundance of β 2 -AR (β 2 -AR expression is 20 -30% of total β-ARs). The present result also showed that the contribution of β 2 -AR- mediated cAMP production is not affected by disruption of caveolae. β 2 -AR activates adenylyl cyclase more efficiently than β 1 -AR (22) , and Rybin et al. suggest the spatial proximity of β 2 -ARs with the adenylyl cyclase in caveolae. Thus, β 2 -AR may selectively couple with adenylyl cyclase (11) . However, the present results suggest that the localization of β 2 -AR in the caveolae does not contribute to cAMP production linked to PKA activation in rat neonatal cardiomyocytes.
Although β 1 -AR was not localized in the caveolae, β 1 -AR-induced cAMP production was enhanced by the disruption of caveolae with MβCD. Why was β 1 -ARmediated cAMP production enhanced by MβCD treatment? Neonatal cardiomyocytes express two types of adenylyl cyclase: adenylyl cyclase type 5 (AC-V) and type 6 (AC-VI) (23) . These subtypes of AC distribute over the caveolae and other cell fractions. Therefore, it is possible that MβCD treatment releases AC-V and AC-VI from the caveolae, and the two ACs couple with β 1 -AR outside of the caveolae. Rybin et al. reported that cholesterol depletion enhances isoproterenol-and zinterol-dependent cAMP production in rat neonatal cardiomyocytes (11) . As AC-VI is inhibited by Ca 2+ , they suggested that this enhancement is attributed to elimination of AC-VI inhibition by Ca 2+ increased through capacitative calcium entry channels that are localized in the caveolae (24) . There is another possibility to explain the enhancement of cAMP production without affecting the relative contribution of each subtype to cAMP production. MβCD binds cholesterol and extracts it from the plasma membrane. The content of cholesterol influences the membrane fluidity that is important for receptor-G protein-AC coupling. MβCD treatment may enhance cAMP production by increasing membrane fluidity. MβCD treatment did not enhance cAMP production by forskolin (data not shown), suggesting that enhancement of cAMP production with MβCD treatment is not the relief of inhibition of AC-VI.
Regulatory subunit type II of PKA is abundant in caveolae, while regulatory subunit type I is excluded from caveolae in rat neonatal cardiomyocytes and canine cardiac tissues. The present result showed that β 1 -and β 2 -ARs stimulation increased cAMP production, but PKA was activated only by β 1 -AR stimulation, which was independent of caveolae. Therefore, β 1 -AR may activate a specific subtype of PKA that is excluded from caveolae. Catecholamine action in the heart is predominantly mediated by β 1 -AR, and consequent PKA activation alters contractile function by phosphorylating L-type calcium channel, phospholamban, and troponin I. These phosphorylation events may also depend on a specific PKA subtype.
In conclusion, we examined the effect of MβCD on cAMP production and PKA activation. We showed that caveolae do not play a major role in PKA activation induced by β 1 -AR stimulation. These results support the recent concept that β 1 -and β 2 -ARs transduce different signaling pathways in myocytes.
